Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kimura, Y."" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Autorzy:
Ito T; Department of Gastroenterology and Hepatology, International University of Health and Welfare Graduate School of Medicine, Fukuoka, Japan.; Neuroendocrine Tumor Centre, Fukuoka Sanno Hospital, Fukuoka, Japan.
Fujimori N; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Honma Y; Head and Neck Medical Oncology Division and Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Kudo A; Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Hijioka S; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Katsushima S; Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Kimura Y; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University Hospital, Sapporo, Japan.
Fukutomi A; Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Hisamatsu S; Pharmaceutical Research & Development Division, Teijin Pharma Limited, Tokyo, Japan.
Nakajima A; Pharmaceutical Research & Development Division, Teijin Pharma Limited, Tokyo, Japan.
Shimatsu A; Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Oct; Vol. 17 (5), pp. e153-e161. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Antineoplastic Agents*/adverse effects
Neuroendocrine Tumors*/drug therapy
Humans ; Japan ; Peptides, Cyclic/adverse effects ; Somatostatin/analogs & derivatives
Czasopismo naukowe
Tytuł:
Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
Autorzy:
Goi T; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Naruse T; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Kimura Y; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Fujimoto D; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Morikawa M; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Koneri K; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Yamaguchi A; First Department of Surgery, University of Fukui, 23-3, Eiheiji-cho, Yoshida-gun, Fukui, 9101193, Japan. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2015 Oct 09; Vol. 13, pp. 296. Date of Electronic Publication: 2015 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*
Antineoplastic Agents/*administration & dosage
Colorectal Neoplasms/*secondary
Fluorouracil/*administration & dosage
Liver Neoplasms/*drug therapy
Liver Neoplasms/*secondary
Aged ; Aged, 80 and over ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/mortality ; Female ; Hepatic Artery ; Humans ; Infusions, Intra-Arterial ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies